Novel pharmacological approaches for antiarrhythmic therapy

  title={Novel pharmacological approaches for antiarrhythmic therapy},
  author={Ursula Ravens},
  journal={Naunyn-Schmiedeberg's Archives of Pharmacology},
Arrhythmias are caused by the perturbation of physiological impulse formation, impaired conduction, or disturbed electrical recovery. Currently available antiarrhythmic drugs—perhaps with exception of amiodarone—are not sufficiently effective and are burdened by cardiac and extracardiac side effects that may offset their therapeutic benefits. Detailed knowledge about electrical and structural remodelling may provide a better understanding of the mechanisms leading to generation and maintenance… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 10 extracted citations

Emerging antiarrhythmic agents: a personal view from the Far East.

Expert opinion on emerging drugs • 2011
View 11 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 82 references

Regulation of twoporedomain ( K 2 P ) potassium leak channels by the tyrosine kinase inhibitor genistein

J Gierten, E Ficker, +10 authors D Thomas
Br J Pharmacol • 2008
View 11 Excerpts
Highly Influenced

Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target

Naunyn-Schmiedeberg's Archives of Pharmacology • 2009
View 9 Excerpts
Highly Influenced

Cardiac adrenergic control and atrial fibrillation

Naunyn-Schmiedeberg's Archives of Pharmacology • 2009
View 4 Excerpts
Highly Influenced

Roles of TRP channels in the development of cardiac hypertrophy

Naunyn-Schmiedeberg's Archives of Pharmacology • 2008
View 3 Excerpts
Highly Influenced

Burashnikov A (2009) Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation

C Antzelevitch
J Electrocardiol • 2009

Similar Papers

Loading similar papers…